Sign up for Table of Contents Alerts.
Email this page
Print this page
Extra Views
The role of the p53 pathway in the treatment of follicular lymphoma
Laurent Knoops and Daphne de Jong
volume 7 | issue 4
15 February 2008Pages: 436 - 439
Subscribe to this journal for $129/year
Low dose radiotherapy is an effective palliative treatment for follicular lymphoma, inducing the rapid apoptosis of the neoplastic B cells. Comparison of the gene expression profiles of follicular lymphoma biopsy samples taken before and after radiation shows that the intact p53 pathway is the driving force to the apoptotic process. Death of the Bcl-2 overexpressing B cells can be explained by the prominent induction of the extrinsic apoptotic pathway, with an active role of the neoplastic microenvironnement for the expression of death receptor ligands and the clearance of the apoptotic cells. These insights have implications for the design of new protocols in the treatment of follicular lymphoma.
Authors
Laurent Knoops
Université catholique de Louvain; Brussels, Belgium
Daphne de Jong
The Netherlands Cancer Institute; Amsterdam, The Netherlands




